Free Trial

Gyre Therapeutics (GYRE) Insider Trading & Ownership

Gyre Therapeutics logo
$12.91 -0.01 (-0.08%)
(As of 11/20/2024 ET)

Gyre Therapeutics (NASDAQ:GYRE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.52%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$324,024.00
Get GYRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GYRE Insider Buying and Selling by Quarter

Gyre Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/28/2024Nassim UsmanDirectorSell3,452$12.00$41,424.00  
5/1/2024Nassim UsmanDirectorSell20,000$14.13$282,600.00  
(Data available from 1/1/2013 forward)

GYRE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Gyre Therapeutics includes Nassim Usman. Learn more on insiders at GYRE.

19.52% of Gyre Therapeutics stock is owned by insiders. Learn more on GYRE's insider holdings.

The following insider sold GYRE shares in the last 24 months: Nassim Usman ($324,024.00).

Insiders have sold a total of 23,452 Gyre Therapeutics shares in the last 24 months for a total of $324,024.00 sold.

Gyre Therapeutics Key Executives

  • Dr. Han Ying Ph.D.
    CEO & Director
  • Mr. Songjiang Ma
    President & Director
  • Ms. Ruoyu Chen (Age 54)
    Interim Chief Financial Officer
  • Mr. Weiguo Ye
    Chief Operating Officer
  • Ms. Seline E. Miller CPA (Age 55)
    Senior Vice President of Finance


This page (NASDAQ:GYRE) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners